~~<i id='D7B7BB65A0'><strike id='D7B7BB65A0'><tt id='D7B7BB65A0'><pre id='D7B7BB65A0'></pre></tt></strike></i>~~

Home» explore» explore

explore

author：knowledge 2025-09-30 22:44:09 Page View：55

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： House GOP plan to stem drug shortages differs from Democrats’
Next article： Medicare details structure of new drug price negotiation program

Wikipedia

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Create a giant ice tray with this foil pan hack to keep food cold this summer

2:22Afoiltrayfilledwithwatertobefrozen.DanMcCarthyMakesummerentertainingabreezewiththisoversizedicet

United colonoscopy coverage change 'may cost lives,' doctors say

AdobeWhengastroenterologistslearnedinMarchthatUnitedHealthcareplanstobarricademanycolonoscopiesbehin

House GOP plan to stem drug shortages differs from Democrats’

Rep.CathyMcMorrisRodgers(R-Wash.),chairoftheHouseEnergyandCommerceCommittee.AnnaMoneymaker/GettyImag